The Farapulse PFA system provides a non-thermal approach for ablating heart tissue related to atrial fibrillation.

Boston Scientific announced its acquisition of ... markets and, notably, its WATCHMAN device in its structural heart portfolio. EP helps to identify irregular heart rhythms and delivers energy ...

Boston Scientific Corporation BSX recently received the Pharmaceuticals and Medical Device Agency’s (“PMDA”) approval in ...

A medical milestone has been achieved in Deep East Texas as the first Left Atrial Appendage Occlusion (LAAO) procedure ...

Boston Scientific gets PDMA approval in Japan for FARAPULSE PFA System: Marlborough, Massachusetts Monday, September 30, 2024, 13:00 Hrs [IST] Boston Scientific Corporation, a glo ...

27, 2024 /PRNewswire/ -- Boston Scientific Corporation ... PFA System for cardiac ablation and the WATCHMAN FLX™ Pro Left Atrial Appendage Closure Device. Boston Scientific plans to launch ...

Boston Scientific, a Marlborough medical device manufacturer, has officially closed its acquisition of California medical device maker Silk Road Medical, almost exactly three months to the day ...

The Boston Scientific Mobile Learning Lab visited the St. Peter’s Hospital campus on Thursday, September 19, offering clinical staff an opportunity to take part in high-tech, interactive ...

Boston Scientific Corporation (NYSE: BSX) announced it has received Pharmaceuticals and Medical Device Agency (PMDA) approval in Japan for the FARAPULSE™ Pulsed Field Ablation (PFA) System. The ...

Boston Scientific Corp. (BSX) announced Friday that it has received Pharmaceuticals and Medical Device Agency approval in Japan for ...

MARLBOROUGH, Mass., Sept. 27, 2024 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) announced it has received Pharmaceuticals and Medical Device Agency (PMDA) approval in Japan for the ...